Since our results demonstrate that LEDGF/p75 and CLU are upregulated in the absence of androgen via GR, future combinatorial therapies co-targeting AR, GR, and stress oncoproteins could potentially confer greater overall survival to patients with advanced PCa. This evidence concerns the gene NR3C1 and posterior cortical atrophy.